Jonathan Lim
Founder at BOUNDLESS BIO, INC.
Net worth: 69 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Zachary Hornby | M | 45 |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA.
City Hill Ventures LLC
City Hill Ventures LLC Investment ManagersFinance City Hill Ventures LLC (City Hill Ventures) is a venture capital firm founded in 2010 by Jonathan Lim. The firm is headquartered in San Diego, California. | 15 years |
Keith Lenden | M | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 7 years |
Kristina Burow | F | 50 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 22 years |
Alexander Casdin | M | 56 | 11 years | |
James Bristol | M | 77 | 10 years | |
Charles Homcy | M | 75 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | - |
Robert Shoemaker | M | 43 |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | 6 years |
Connie Matsui | F | 70 | 18 years | |
Marc Tessier-Lavigne | M | 64 |
Stanford University
| 9 years |
Pratik Multani | M | 57 | 9 years | |
Mark A. McDonnell | M | 55 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 25 years |
Jason V. Coloma | M | - |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | - |
Valerie Start | M | 64 | 9 years | |
Michael LaBarre | M | 60 | 16 years | |
Jerry Yang | M | 54 |
Stanford University
| 18 years |
Arun Majumdar | M | 60 |
Stanford University
| 10 years |
Bernard Parker | M | - | 9 years | |
Michael Genesereth | M | - |
Stanford University
| - |
Catherine Sohn | M | 71 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 3 years |
Julie Hambleton | M | 66 | 3 years | |
Thomas Daniel | M | 70 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin.
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 6 years |
Jean-Michel Vernier | M | 63 |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | 11 years |
Christine Brennan | M | 56 | 2 years | |
Amy Zegart | M | 56 |
Stanford University
| - |
Ari Nowacek | M | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 9 years |
Sean Kendall | M | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 9 years |
Corey Ritter | M | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 7 years |
Nilay Thakar | M | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | - |
Carol Suh | F | 33 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 6 years |
Sekar Kathiresan | M | 52 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 2 years |
David Chacko | M | 41 | 5 years | |
Ebun Garner | M | 52 | 3 years | |
Jeffery Kelly | M | 63 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 24 years |
Michael Varney | M | 65 | 4 years | |
Scott Minick | M | 72 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 26 years |
Paul Schimmel | M | 83 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 27 years |
Clinton Bybee | M | 61 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 36 years |
Keith Crandell | M | 63 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 38 years |
Jean Liu | F | 55 | 2 years | |
Lynn Schenk | F | 79 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
Robert Nelsen | M | 60 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 38 years |
John Morgridge | M | 91 |
Stanford University
| - |
Donald R. Shepherd | M | 87 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
Steven Gillis | M | 71 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 19 years |
Paul Koontz | M | 64 |
Stanford University
| - |
Paul Berns | M | 57 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | - |
Olivia Zetter | F | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | 2 years |
Douglas A. Bingham | M | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
Michael A. Marletta | M | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
Donna J. Weston | F | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
Stephen C. Perry | M | - |
Stanford University
| - |
Donna J. H. Novitsky | F | - |
Stanford University
| - |
Charles Young | M | 55 |
Stanford University
| 6 years |
Michael Fischbach | M | 43 |
Stanford University
| 7 years |
Aneel Bhusri | M | 58 |
Stanford University
| 5 years |
John Francis Cogan | M | 76 |
Stanford University
| 44 years |
Arnold R. Weber | M | 94 |
Stanford University
| - |
Frank M. Longo | M | - |
Stanford University
| 18 years |
David Carroll | M | 67 |
Stanford University
| - |
Jenny Dearborn | F | - |
Stanford University
| 2 years |
Vaughan Pratt | M | - |
Stanford University
| - |
Bryan White | M | - |
Stanford University
| - |
Naomi Boness | M | 47 |
Stanford University
| 5 years |
Persis Drell | M | 68 |
Stanford University
| - |
Carl E. Thoresen | M | - |
Stanford University
| - |
Llan M. Kroo | M | - |
Stanford University
| - |
Brook Byers | M | 78 |
Stanford University
| - |
Christof Wittig | M | - |
Stanford University
| - |
John Edson | M | - |
Stanford University
| - |
John W. Jarve | M | 68 |
Stanford University
| - |
Edward D. Harris | M | 86 |
Stanford University
| - |
Dan Boneh | M | - |
Stanford University
| - |
Randall Livingston | M | 70 |
Stanford University
| 23 years |
Mary Barra | F | 61 |
Stanford University
| - |
Lillian Bloch | F | - |
Stanford University
| - |
Chien Lee | M | 70 |
Stanford University
| - |
John Howard | M | - |
Stanford University
| 35 years |
Dave Burke | M | - |
Stanford University
| 6 years |
Barry L. Marrs | M | - |
Stanford University
| - |
Pamela Matson | M | - |
Stanford University
| - |
Maria Grazia Roncarolo | M | 69 |
Stanford University
| 10 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Ramsay | M | 59 |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | 15 years |
Kathryn Falberg | F | 63 | 9 years | |
James L. Freddo | M | 69 | 4 years | |
Kenneth Kelley | M | 64 | 17 years | |
Graeme Roy Kaufman | M | 74 | 4 years | |
Kurt Gustafson | M | 56 | 4 years | |
Christopher Reyes | M | - |
Eclipse Therapeutics, Inc.
Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | - |
Peter Chu | M | - |
Eclipse Therapeutics, Inc.
Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | - |
Gary Yeung | M | - | 2 years | |
Petr Johanes | M | - |
Stanford University
| 12 years |
Pin Pin Tea-Mankorn | F | - |
Stanford University
| 10 years |
Rod A. Beckstrom | M | - |
Stanford University
| 3 years |
Cody Evans | M | - |
Stanford University
| 2 years |
sharon huang | F | - |
Stanford University
| 5 years |
Looi Qin En | M | - |
Stanford University
| 5 years |
David McColl | M | - |
Stanford University
| 6 years |
William George | M | - |
Stanford University
| 2 years |
Lucio Tan | M | 31 |
Stanford University
| 6 years |
Rudigier Martin | M | - |
Stanford University
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Australia | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Lim
- Personal Network